Adagene Inc (ADAG)
2.246
-0.06
(-2.79%)
USD |
NASDAQ |
May 07, 16:00
2.19
-0.06
(-2.47%)
After-Hours: 20:00
Adagene Total Long Term Debt (Quarterly): 21.94M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.94M |
| June 30, 2023 | 24.94M |
| December 31, 2022 | 27.77M |
| June 30, 2022 | 16.57M |
| Date | Value |
|---|---|
| December 31, 2021 | 7.489M |
| June 30, 2021 | 7.674M |
| June 30, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
27.77M
Maximum
Dec 2022
15.20M
Average
16.57M
Median
Jun 2022
Total Long Term Debt (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 253.91M |
| CASI Pharmaceuticals Inc | 18.90M |
| Zai Lab Ltd | 0.00 |
| I-MAB | 12.54M |
| Gracell Biotechnologies Inc (DELISTED) | -- |